alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               SEP-30-1996
<CASH>                                               8
<SECURITIES>                                         0
<RECEIVABLES>                                       57
<ALLOWANCES>                                         6
<INVENTORY>                                         33
<CURRENT-ASSETS>                                   941
<PP&E>                                             240
<DEPRECIATION>                                      72
<TOTAL-ASSETS>                                    1110
<CURRENT-LIABILITIES>                              187
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                         15
<COMMON>                                             4
<OTHER-SE>                                         860
<TOTAL-LIABILITY-AND-EQUITY>                      1110
<SALES>                                            976
<TOTAL-REVENUES>                                   976
<CGS>                                              469
<TOTAL-COSTS>                                      469
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                    212
<INCOME-TAX>                                        87
<INCOME-CONTINUING>                                125
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       125
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
IN THE UNITED STATES DISTRICT COURT

FOR THE WESTERN DISTRICT OF TEXAS

AUSTIN DIVISION

KENNETH BELL, ET AL, 

Plaintiff,

v.

CAL-MAINE FOODS, ET AL,

Defendants.

§

§

§

§

§

§

§

§

Civil Action No. 1:20-cv-00461-RP

ORDER GRANTING STATE OF TEXAS’S UNOPPOSED MOTION TO

WITHDRAW AS COUNSEL AND 

DESIGNATION OF ATTORNEY-IN-CHARGE

The Court having considered the State of Texas’s Unopposed Motion to Withdraw 

as Counsel and Designation of Attorney-in-Charge. After reviewing the Motion, and for 

good cause having been demonstrated the Court finds that the motion [Dkt. 154] should be 

GRANTED.

IT IS THEREFORE ORDERED that Francesca A. Di Troia is hereby granted leave 

to withdraw as counsel of record for Intervenor the State of Texas in this matter.

IT IS FURTHER ORDERED that Ryan G. Kercher is hereby designated as 

Attorney-in-Charge for Intervenor the State of Texas.

SIGNED this ____ day of ______________________, 2021.

ROBERT PITMAN

United States District Judge

Case 1:20-cv-00461-RP Document 154-1 Filed 03/18/21 Page 1 of 1
YVELAN PIERRE,

Appellant,

v.

STATE OF FLORIDA,

Appellee.

IN THE DISTRICT COURT OF APPEAL

FIRST DISTRICT, STATE OF FLORIDA

NOT FINAL UNTIL TIME EXPIRES TO 

FILE MOTION FOR REHEARING AND 

DISPOSITION THEREOF IF FILED

CASE NO. 1D15-5902

_____________________________/

Opinion filed March 4, 2016.

An appeal from an order of the Circuit Court for Duval County.

Tatiana Salvador, Judge.

Yvelan Pierre, pro se, Appellant.

Pamela Jo Bondi, Attorney General, and Heather Flanagan Ross, Assistant 

Attorney General, Tallahassee, for Appellee.

PER CURIAM.

AFFIRMED.

WETHERELL, ROWE, and OSTERHAUS, JJ., CONCUR.
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5598 Introduced in House (IH)]

112th CONGRESS
  2d Session
                                H. R. 5598

    To extend the temporary suspension of duty on mixtures of C5-18 
perfluorocarbon alkanes, perfluorocarbon amines, and/or perfluorocarbon 
                                ethers.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                              May 8, 2012

 Mr. Ellison introduced the following bill; which was referred to the 
                      Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
    To extend the temporary suspension of duty on mixtures of C5-18 
perfluorocarbon alkanes, perfluorocarbon amines, and/or perfluorocarbon 
                                ethers.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. MIXTURES OF C5-18 PERFLUOROCARBON ALKANES, PERFLUOROCARBON 
              AMINES, AND/OR PERFLUOROCARBON ETHERS.

    (a) In General.--Heading 9902.40.88 of the Harmonized Tariff 
Schedule of the United States (relating to mixtures of C5-18 
perfluorocarbon alkanes, perfluorocarbon amines, and/or perfluorocarbon 
ethers) is amended by striking the date in the effective period column 
and inserting ``12/31/2015''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of enactment of 
this Act.
                                 <all>
```
EXHIBIT 32.2

CERTIFICATION OF CFO PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 10-K of Newcastle Investment Corp. (the ‘‘Company’’) for the annual period ended December 31, 2007 as filed with the Securities and Exchange Commission on the date hereof (the ‘‘Report’’), Debra A. Hess, as Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of her knowledge:

| |     |                                                                                                                      
| | --- | ---------------------------------------------------------------------------------------------------------------------
| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

| |     |                                                                                                                                                     
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------
| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/Debra A. Hess
Debra A. Hess
Chief Financial Officer
February 29, 2008

This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

---
# United States Court of Appeals **for the Fifth Circuit**

____________ No. 23-40518 Summary Calendar

____________ United States of America, Plaintiff—Appellee ,

versus Roque Geovanni Sosa-Guerrero, Defendant—Appellant

.

______________________________ Appeal from the United States District Court for the Southern District of Texas USDC No. 7:23-CR-549-1

______________________________ Before Higginbotham, Stewart, and Southwick, Circuit Judges

. Per Curiam: * The Federal Public Defender appoin ted to represent Roque Geovanni Sosa-Guerrero has moved for leave to withdraw and has filed a brief in accordance with Anders v. California , 386 U.S. 738 (1967), and United States v. Flores , 632 F.3d 229 (5th Cir. 2011). Sosa-Guerrero has not filed a response. We have reviewed counsel’s brief and the relevant portions of the

_____________________

* This opinion is not designated for publication. See 5th Cir. R. 47.5. United States Court of Appeals Fifth Circuit 

### FILED March 8, 2024 Lyle W. Cayce Clerk Case: 23-40518 Document: 36-1 Page: 1 Date Filed: 03/08/2024No. 23-40518

2 record reflected therein. We concur with counsel’s assessment that the appeal presents no nonfrivolous issu e for appellate review. Accordingly, counsel’s motion for leave to withdraw is GRANTED , counsel is excused from further responsibilitie s herein, and the appeal is DISMISSED

. See 5th Cir. R. 42.2. Case: 23-40518 Document: 36-1 Page: 2 Date Filed: 03/08/2024
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4667 Introduced in House (IH)]

112th CONGRESS
  2d Session
                                H. R. 4667

    To extend the temporary suspension of duty on Isoxadifen-Ethyl.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             April 25, 2012

 Mr. Cleaver introduced the following bill; which was referred to the 
                      Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
    To extend the temporary suspension of duty on Isoxadifen-Ethyl.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. ISOXADIFEN-ETHYL.

    (a) In General.--Heading 9902.11.45 of the Harmonized Tariff 
Schedule of the United States (relating to Isoxadifen-Ethyl) is amended 
by striking ``12/31/2012'' and inserting ``12/31/2015''.
    (b) Effective Date.--The amendments made by subsection (a) apply 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of enactment of 
this Act.
                                 <all>
```
I 

112TH CONGRESS 

2D SESSION H. R. 5514 

To suspend temporarily the rate of duty on Modified VinylchlorideHydroxypropylacrylate copolymer. 

IN THE HOUSE OF REPRESENTATIVES 

MAY 7, 2012 

Mr. WALBERG introduced the following bill; which was referred to the 

Committee on Ways and Means 

A BILL 

To suspend temporarily the rate of duty on Modified 

Vinylchloride-Hydroxypropylacrylate copolymer. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. MODIFIED VINYLCHLORIDE4 HYDROXYPROPYLACRYLATE COPOLYMER. 

5 (a) IN GENERAL.—Subchapter II of chapter 99 of 

6 the Harmonized Tariff Schedule of the United States is 

7 amended by inserting in numerical sequence the following 

8 new heading: 


tjames on DSK6SPTVN1PROD with BILLS
2 

•HR 5514 IH

‘‘ 9902.01.00 Modified VinylchlorideHydroxypropylacrylate copolymer (CAS No. 

114653–42–8) (provided 

for in subheading 

3904.40.00) ....................... Free No change No change On or before 

12/31/2015 ’’. 

1 (b) EFFECTIVE DATE.—The amendment made by 

2 subsection (a) applies to articles entered, or withdrawn 

3 from warehouse for consumption, on or after the 15th day 

4 after the date of the enactment of this Act. 

Æ 


tjames on DSK6SPTVN1PROD with BILLS
% Predict blood CPY and urine TCPY levels

% Drinking water concentrations from Bulb Onion_GAOnion_WirringSTD_Reservoir_Parent_TSadj.xlsx % From 12/31/1964 to 3/31/1965 % Infants % Cecilia Tan % January 22, 2016

% Setting model parameters use human_parameters_MRP use preg_female_parameters BWSW=1; % Set body weight to a fixed value BWST=4.85; % Set body weight to 4.85 kg for infants PREG=0; % Not pregnant DT(1) = 0.0; DORAL(1) = 0.0; TSTOP=2904; %Simulation time

%TO READ IN DOSES FROM AN EXCEL SPREADSHEET. must be saved as .xls VOLUME=0.68557 % Water consumption volume in L/DAY EVENTS=6 % Drinking frequency per day DT = xlsRead("Drinkingwater.xls", "infant", "A2:A728") ; % Dosing Times AMTCDOSE=xlsRead("Drinkingwater.xls", "infant", "B2:B728")*VOLUME/EVENTS; % Dose in ug/l

% Output RBC AChE, venous blood conc for cpf, urine TCPY conc, venous blood conc for oxon prepare time rbcce cv urinetcpy cvo start@nocallback

mytable = [_time _rbcce _urinetcpy _cv*350.6 _cvo*334.5]; % Output unit ug/L for concentrations save mytable @file='onion_infant_01222016.txt' @format=ascii
* Pursuant to 5 TH C IRCUIT R ULE 47.5, the court has determined

that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH C IRCUIT R ULE 47.5.4. 1 United States Court of Appeals Fifth Circuit 

## FILED June 13, 2005 Charles R. Fulbruge III Clerk IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

_______________________ No. 04-51129 Summary Calendar

_______________________ MAYNARD L. TUCKER, Plaintiff - Appellant,

v. COX TEXAS NEWSPAPERS, L.P., doing business as The Austin American-Statesman; THE AUSTIN HUMAN RIGHTS COMMISSION,

Defendants - Appellees,

_______________________ Appeal from the United States District Court for the Western District of Texas

_______________________ Before JONES, BARKSDALE and PRADO, Circuit Judges. PER CURIAM: * Appellant Maynard L. Tucker challenges the district court’s denial of his motion to remand. Because we lack jurisdiction to review the district court’s order, we dismiss this appeal. Tucker sued his former employer Cox Texas Newspapers (“Cox”) and The Austin Human Rights Commission (“AHRC”) in Texas state court. In this suit, Tucker alleges that Cox violated Title VII1 42 U.S.C. § 2000e et seq . (2000).
229 U.S.C. § 621 et seq . (1994). 2 of the Civil Rights Act of 1964 1 and the Age Discrimination in Employment Act 2 by discriminating against Tucker because of his age and race. Tucker also contends that AHRC did not properly investigate his claims of discrimination. The two defendants removed the case to federal district court, stating that it presented a federal question. Tucker moved to remand the case. The district court denied the motion and ruled that the case was removable because it was based on federal law. In response, Tucker filed a request for appeal, which the district court construed as a notice of appeal. This request only addressed the merits of his motion to remand. Tucker did not seek, nor did the district court grant, permission under 28 U.S.C. § 1292(b) to appeal an interlocutory order. This court has jurisdiction to review final orders. 28 U.S.C. § 1291. A order denying a request for remand is not a final order, and without certification under 28 U.S.C. § 1292(b), we lack jurisdiction to review it. Melancon v. Texaco, Inc. , 659 F.2d 551, 552-53 (5th Cir. 1981). Because the district court did not certify this order, we cannot consider Tucker’s appeal. APPEAL DISMISSED.
```

[Federal Register Volume 65, Number 196 (Tuesday, October 10, 2000)]
[Notices]
[Page 60202]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-25890]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood Institute; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Clinical Trials Review Committee.
    Date: October 29-30, 2000.
    Time: 6:30 to 1:30 pm.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency, One Metro Center, Bethesda, MD 20814.
    Contact Person: Joyce A. Hunter, Review Branch, Room 7192, 
Division of Extramural Affairs, National Heart, Lung, and Blood 
Institute, National Institutes of Health, Bethesda, MD 20892-7924, 
301/435-0277.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: September 29, 2000.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 00-25890 Filed 10-6-00; 8:45 am]
BILLING CODE 4140-01-M
```
#### Allan Mionis, by His Guardian ad Litem Sol Mionis, et al., Respondents, *v.*Merchants Mutual Casualty Company, Appellant.

Supreme Court, Appellate Term, Second Department,

March 12, 1957.

*Robert Hill Nix*for appellant.

*Philip T. Peiring*for respondents.

*Per Curiam.*

Plaintiff as judgment creditor of the insured had no greater rights against the defendant insurance company than those of an insured seeking repayment from his company *(Rushing*v. *Commercial Cas. Ins. Co.,*251 N. Y. 302; *Shalita*v. *358
      *American Motorists Ins. Co.,*266 App. Div. 131, motion for leave to appeal denied 266 App. Div. 885, motion for leave to appeal denied 291 N. Y. 831).

The absence and nonavailability of the insured in the original action was prima facie proof of the insured’s breach of the terms and conditions of the policy; the insured’s failure to co-operate with the insurer, caused by his absence, was a breach of the policy. The plaintiff was thereupon required to come forward with an explanation or excuse of such absence and, having failed to do so, the uncontroverted proof of the defendant established the insured’s breach of the terms and conditions of the policy *(Schoenfeld*v. *New Jersey Fidelity & Plate Glass Ins. Co.,*203 App. Div. 796; *Shalita*v. *American Motorists Ins. Co.,*supra; *Rushing*v. *Commercial Cas. Ins. Co., supra).*

The conduct of the defendant company in the defense of the original action, despite the absence of the insured defendant, up until the point where the answer of the insured defendant was stricken out for failure to appear for an examination before trial, was proper and did not constitute a waiver of defendant’s right to disclaim liability *(Briskman*v. *Glen Falls Ind. Co.,*251 App. Div. 319; *Shalita*v. *American Motorists Ins. Co., supra).*

The defendant company was not bound to anticipate that the insured would not appear in time for the trial. But that having occurred, the defendant company’s withdrawal, because of the absence of the insured and the impossibility of providing a defense, was sufficient to preserve its choice to stand at least upon that ultimate breach of the contract *(Briskman*v. *Glens Falls Ind. Co.,*supra; *Shalita*v. *American Motorists Ins. Co., supra).*

The judgment should be unanimously reversed on the law and facts, with costs to the defendant, and judgment directed for the defendant dismissing the complaint, with costs.

Pette, Arkwright and Brown, JJ., concur.

Judgment reversed, etc.
Exhibit 32.1

CERTIFICATION

The following statement is being furnished to the Securities and Exchange Commission solely for purposes of Section 906
of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350), which carries with it certain criminal penalties in the event of a knowing or willful misrepresentation.

In accordance with the requirements of Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350), each of the undersigned hereby certifies that, to the best of their knowledge:



| | (i) | This Current Report on Form 10-Q of Spectrum Control, Inc. for the period ended August 31, 2009, (the Report) fully complies with the requirements of section 13 (a) or
15 (d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o (d)); and
| | --- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | (ii) | The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of Spectrum Control, Inc.
| | ---- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------

Dated as of this 25th day of September 2009.



|                                      |  |  |  |                                                  
|------------------------------------- |  |  |  | -------------------------------------------------
|/s/    RICHARD A. SOUTHWORTH          |  |  |  | /s/    JOHN P. FREEMAN                           
|President and Chief Executive Officer |  |  |  | Senior Vice President and Chief Financial Officer

A signed original of this written statement required by Section 906 has been provided to Spectrum Control, Inc. and
will be retained by Spectrum Control, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.



34
IN THE UNITED STATES DISTRICT COURT

FOR THE WESTERN DISTRICT OF TEXAS

WACO DIVISION

WSOU INVESTMENTS, LLC d/b/a BRAZOS 

LICENSING AND DEVELOPMENT,

Plaintiff,

v.

DELL TECHNOLOGIES INC., DELL INC., 

EMC CORPORATION, AND VMWARE, INC.

Defendants.

Case No. 6:20-cv-00485-ADA

JURY TRIAL DEMANDED

LETTER OF REQUEST FOR FOREIGN DISCOVERY
1

Defendants Dell Technologies Inc., Dell Inc., EMC Corporation, and VMware, Inc. 

(collectively “Defendants”) seek foreign discovery from third party witnesses residing in the 

Netherlands. Defendants have attached an Appendix with a Letter of Request which includes

Document Requests and Deposition Topics. Defendants respectfully request that the Court execute 

the Letter of Request attached as Appendix H. Defendants further request that, after the Court has 

signed the Letter of Request, the Clerk of this Court authenticate the Court’s signature under the 

seal of this Court, and return the original signed and sealed executed Letter, and two certified 

copies of the signed and sealed executed Letters, to Defendants’ counsel, Barry K. Shelton, for 

delivery to the proper authority.

Plaintiff, WSOU Investments, LLC d/b/a Brazos Licensing and Development, indicated 

that it reserves the right to serve its own foreign discovery in the future.

Dated: November 6, 2020 By: /s/ Barry K. Shelton

Barry K. Shelton

Texas State Bar No. 24055029

bshelton@sheltoncoburn.com

SHELTON COBURN LLP

311 RR 620, Ste. 205

Austin, TX 78734-4775 

Telephone: 512.263.2165

Facsimile: 512.263.2166 

Attorneys for Defendants
2

CERTIFICATE OF SERVICE

The undersigned certifies that on November 6, 2020, all counsel of record who are deemed 

to have consented to electronic service are being served with a copy of this document through the 

Court’s CM/ECF system under Local Rule CV-5(b)(1). 

/s/ Barry K. Shelton

Barry K. Shelton